Document Classification

Section Type: RESULTS

Text: Holter monitoring data were variable but showed no clinically meaningful differences between the formoterol and placebo groups, respectively, for variables such as (mean + / - SD at end of treatment) : heart rate (80 + / -8. 6 vs. 80 + / -10. 6 bpm), number and rate of ventricular premature beats (total 732 + / -2685. 4 vs. 650 + / -2090. 6 ; rate 35 + / -131. 0 vs. 30 + / -101. 3 per h), ventricular tachycardia events (total 0. 4 + / -1. 70 vs. 1. 0 + / -9. 23 ; rate 0. 02 + / -0. 082 vs. 0. 05 + / -0. 479 per h), and supraventricular premature beats (total 504 + / -1844. 1 vs. 823 + / -2961. 8 ; rate 22 + / -80. 6 vs. 37 + / -129. 6 per h).